<p>Histogram showing number of women with drug resistant HIV infection that had each of the following protease inhibitor (PI), nucleoside reverse transcriptase inhibitor (NRTI) or non-nucleoside reverse transcriptase inhibitor (NNRTI) mutations M46L, I85V, K65R, L74I, K219E, M184V, K101E, V106M, Y181C or G190A. Resistance mutations were identified using the Stanford Calibrated Population Resistance Tool.</p
<p>ART: antiretroviral treatment. PI: protease inhibitor. NRTI: nucleoside reverse transcriptase inh...
Purpose: There has been an increase in the number of individuals administered antiretroviral therap...
Of the 470 pregnant women living with HIV on ART for ≥4 months, 57 (12.1%) had unsuppressed plasma v...
<p>Frequency of Nucleoside Reverse Transcriptase Inhibitor-related drug resistance mutations [A], Fr...
<p>SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...
<p>Abbreviations: NRTI; nucleoside reverse transcriptase inhibitor, NNRTI; non-nucleoside reverse tr...
<p>IAS-USA, the international Antiviral society-USA; NRTI, nucleoside reverse transcriptase inhibito...
<p>N(<b>t</b>)RTI(s)- nucleoside(tide) reverse transcriptase inhibitor; NNRTI – non-nucleoside rever...
Determining the phenotypic impacts of reverse transcriptase (RT) mutations on individual nucleoside ...
<p><sup>a</sup> Frequency in individuals with pre-ART drug resistance (PDR; defined with the WHO lis...
Background. It is important, for drug-resistance surveillance, to identify human immunodeficiency vi...
Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...
A major concern with using antiretroviral (ARV)-based products for HIV prevention is the potential s...
To assess the prevalence of major drug resistance mutations in antiretroviral (ARV)-treated patients...
Thirty-five HIV-1 infected patients showing clinical and/or immunological failure to first line anti...
<p>ART: antiretroviral treatment. PI: protease inhibitor. NRTI: nucleoside reverse transcriptase inh...
Purpose: There has been an increase in the number of individuals administered antiretroviral therap...
Of the 470 pregnant women living with HIV on ART for ≥4 months, 57 (12.1%) had unsuppressed plasma v...
<p>Frequency of Nucleoside Reverse Transcriptase Inhibitor-related drug resistance mutations [A], Fr...
<p>SDRMs, surveillance drug-resistant mutations; NRTIs, nucleoside reverse transcriptase inhibitors;...
<p>Abbreviations: NRTI; nucleoside reverse transcriptase inhibitor, NNRTI; non-nucleoside reverse tr...
<p>IAS-USA, the international Antiviral society-USA; NRTI, nucleoside reverse transcriptase inhibito...
<p>N(<b>t</b>)RTI(s)- nucleoside(tide) reverse transcriptase inhibitor; NNRTI – non-nucleoside rever...
Determining the phenotypic impacts of reverse transcriptase (RT) mutations on individual nucleoside ...
<p><sup>a</sup> Frequency in individuals with pre-ART drug resistance (PDR; defined with the WHO lis...
Background. It is important, for drug-resistance surveillance, to identify human immunodeficiency vi...
Idue where variability was found in ARV-naïve patients. (N): number of samples from naïve patients h...
A major concern with using antiretroviral (ARV)-based products for HIV prevention is the potential s...
To assess the prevalence of major drug resistance mutations in antiretroviral (ARV)-treated patients...
Thirty-five HIV-1 infected patients showing clinical and/or immunological failure to first line anti...
<p>ART: antiretroviral treatment. PI: protease inhibitor. NRTI: nucleoside reverse transcriptase inh...
Purpose: There has been an increase in the number of individuals administered antiretroviral therap...
Of the 470 pregnant women living with HIV on ART for ≥4 months, 57 (12.1%) had unsuppressed plasma v...